UBS Maintains a 'Buy' on Gilead Sciences (GILD); Raising PT on Lower Risk to HCV

Go back to UBS Maintains a 'Buy' on Gilead Sciences (GILD); Raising PT on Lower Risk to HCV
Gilead Sciences (NASDAQ: GILD) Delayed: 147.60 --0 (-0%)
Previous Close $147.60    52 Week High $108.63 
Open $147.60    52 Week Low $71.39 
Day High $147.60    P/E 81.55 
Day Low $147.60    EPS $1.81 
Volume 8,002